Validation of a new tele-monitoring modality (TeleOX) in patients with interstitial pneumonias

Validation of a new tele-monitoring modality (TeleOX) in patients with interstitial pneumonias - Validation of the performance of TeleOX

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032941

Enrollment

Registered

2018-06-11

Start date

2018-08-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Male or female patients aged 20-85 years 2.Treatment drugs do not matter. 3.Patients with interstitial pneumonias followed at the Department of Respiratory Medicine in Kyoto University Hospital 4.Patients with suspected sleep-related breathing disorders by the examination with pulse-oximeter (PULSOX-300i) or Watch-PAT in the setting of outpatient clinic

Exclusion criteria

Exclusion criteria: 1.Patients are excluded if they are in active phase of acute exacerbation of interstitial pneumonia or respiratory infections; new onset pneumothorax or exacerbation of chronic pneumothorax; or unstable state due to the worsening of other comorbidities (e.g. heart failure, bronchial asthma, and renal failure). 2.Patients are excluded if they are already treated with nasal continuous positive airway pressure therapy for obstructive sleep apnea syndrome.

Design outcomes

Primary

Measure	Time frame
Correlation of the respiratory rate measured by TeleOX and that measured by polysomnography during wakefulness and sleep	—

Secondary

Measure	Time frame
1.Prevalence and severity of sleep related breathing disorders and sleep quality evaluated by questionnaires, including Pittsburg Sleep Quality Index, Japanese version of Epworth Sleepiness Scale, and Japanese version of the Athens Insomnia Scale, in patients with interstitial pneumonias 2.Changes of respiratory rate and percutaneous carbon dioxide partial pressure by oxygen administration 3.Correlation of clinical characteristics and quality of life evaluated by questionnaires, including modified MRC dyspnea scale, Hospital Anxiety and Depression Scale, Idiopathic pulmonary fibrosis-St.Geroge's Respiratory Questionnaire, and Short-Form 36 4.Correlation of percutaneous oxygen saturation and percutaneous carbon dioxide partial pressure and pulmonary arterial pressure measured by transthoracic echocardiography 5.Correlation between clinical characteristics and physical activity evaluated by Actiwatch	—

Measure

Time frame

1.Prevalence and severity of sleep related breathing disorders and sleep quality evaluated by questionnaires, including Pittsburg Sleep Quality Index, Japanese version of Epworth Sleepiness Scale, and Japanese version of the Athens Insomnia Scale, in patients with interstitial pneumonias 2.Changes of respiratory rate and percutaneous carbon dioxide partial pressure by oxygen administration 3.Correlation of clinical characteristics and quality of life evaluated by questionnaires, including modified MRC dyspnea scale, Hospital Anxiety and Depression Scale, Idiopathic pulmonary fibrosis-St.Geroge's Respiratory Questionnaire, and Short-Form 36 4.Correlation of percutaneous oxygen saturation and percutaneous carbon dioxide partial pressure and pulmonary arterial pressure measured by transthoracic echocardiography 5.Correlation between clinical characteristics and physical activity evaluated by Actiwatch

—

Countries

Japan

Contacts

Public ContactTomohiro Handa

Graduate School of Medicine, Kyoto University Department of Advanced Medicine for Respiratory Failure

hanta@kuhp.kyoto-u.ac.jp075-366-7689

Outcome results